ABVD and Stanford V similar for bulky mediastinal Hodgkin’s lymphomaApril 20, 2015Aggressive LymphomasHodgkin Lymphoma
Brentuximab doubles PFS in Hodgkin’s lymphoma patientsMarch 18, 2015Aggressive LymphomasHodgkin Lymphoma
Brentuximab changes landscape for post-transplant Hodgkin’s lymphoma patientsDecember 7, 2014Transfusion MedicineAggressive LymphomasCellular TherapyHodgkin Lymphoma
PD-1 checkpoint inhibitors show mettle against relapsed Hodgkin’s lymphomaDecember 7, 2014Transfusion MedicineAggressive LymphomasHodgkin Lymphoma
Repeat biopsy and long-term surveillance key for rare Hodgkin’s lymphoma subtype June 20, 2014Aggressive LymphomasHodgkin Lymphoma
VIDEO: Idelalisib shows promise in refractory non-Hodgkin lymphomaDecember 10, 2013Aggressive LymphomasHodgkin Lymphoma
No survival benefit for routine surveillance scans in classical Hodgkin diseaseJuly 8, 2013Translational ResearchTransfusion MedicineIndolent LymphomaHodgkin Lymphoma
